Interstitial cystitis: A primary care perspective

Cleveland Clinic Journal of Medicine

Volumn 72, Issue 8, 2005, Pages 698-706

  Rosenberg, Matt ^a   Parsons, C Lowell ^b   Page, Shari ^a  

^a Mid Michigan Health Centers Jackson   (United States)

^b UCSD MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMITRIPTYLINE; BICARBONATE; DIMETHYL SULFOXIDE; HEPARIN; HYDROXYZINE; LIDOCAINE; PENTOSAN POLYSULFATE; POTASSIUM CHLORIDE;

ABDOMINAL PAIN; ALOPECIA; CLINICAL FEATURE; CLINICAL PRACTICE; CONSERVATIVE TREATMENT; CYSTECTOMY; CYSTOSCOPY; DIARRHEA; DRUG DOSE REGIMEN; DYSPAREUNIA; DYSPEPSIA; DYSURIA; FOLLOW UP; HEADACHE; HUMAN; INTERSTITIAL CYSTITIS; NAUSEA; NOCTURIA; PATIENT REFERRAL; PELVIS PAIN SYNDROME; PHYSICAL EXAMINATION; PROVOCATION TEST; QUESTIONNAIRE; RASH; REVIEW; SYMPTOMATOLOGY; URINALYSIS; URINARY FREQUENCY; URINARY URGENCY; URODYNAMICS;

EID: 24344462975     PISSN: 08911150     EISSN: None     Source Type: Journal    
DOI: 10.3949/ccjm.72.8.698     Document Type: Review

References (31)

1. Metts JF. Interstitial cystitis: urgency and frequency syndrome. Am Fam Physician 2001; 64:1199-1214.
2. Driscoll A, Teichman JMH. How do patients with interstitial cystitis present? J Urol 2001; 166:2118-2120.
3. Koziol JA, Clark DC, Gittes RF, Tan EM. The natural history of interstitial cystitis: a survey of 374 patients. J Urol 1993; 149:465-469.
4. Parsons CL. Interstitial cystitis. In: Teichman JMH, editor; Weiss BD, series editor. 20 Common Problems in Urology. New York, NY: McGraw-Hill Medical Publishing Division; 2001:119-132.
5. Parsons CL, Dell J, Stanford EJ, et al. Increased prevalence of interstitial cystitis: previously unrecognized urologic and gynecologic cases identified using a new symptom questionnaire and intravesical potassium sensitivity. Urology 2002; 60:573-578.
6. Curhan GC, Speizer FE, Hunter DJ, Curhan SG, Stampfer MJ. Epidemiology of interstitial cystitis: a population based study. J Urol 1999; 161:549-552.
7. Parsons CL, Tatsis V. Prevalence of interstitial cystitis in young females. Presented at: Research Insights Into Interstitial Cystitis: A Basic and Clinical Science Symposium; October 30-November 1, 2003; Alexandria, Va.
8. Dell JR. Use of the PUF questionnaire to determine the prevalence of IC in obstetrics and gynecology practices. Presented at: Research Insights Into Interstitial Cystitis: A Basic and Clinical Science Symposium. October 30-November 1, 2003; Alexandria, Va.
9. Rosenberg MT, Page S, Roth L, Areaux D, Thallman C, Kval TE. Identification of interstitial cystitis in women in a primary care setting using a symptom questionnaire and potassium sensitivity testing. Presented at: Research Insights Into Interstitial Cystitis: A Basic and Clinical Science Symposium; October 30-November 1, 2003; Alexandria, Va.
10. Rosenberg MT, Hazzard MA. Prevalence of interstitial cystitis symptoms in women: a population-based study in the primary care office. J Urol. In press.
11. Gillenwater JY, Wein AJ. Summary of the National Institute of Arthritis, Diabetes, Digestive and Kidney Diseases Workshop on Interstitial Cystitis, National Institutes of Health, Bethesda, Maryland, August 28-29, 1987. J Urol 1988; 140:203-206.
12. Sant GR, Theoharides TC. The role of the mast cell in interstitial cystitis. Urol Clin North Am 1994; 21:41-53.
13. Hurst RE. Structure, function, and pathology of proteoglycans and glycosaminoglycans in the urinary tract. World J Urol 1994; 12:3-10.
14. Parsons CL, Lilly JD, Stein P. Epithelial dysfunction in nonbacterial cystitis (interstitial cystitis). J Urol 1991; 145:732-735.
15. Parsons CL, Greenberger M, Gabal L, Bidair M, Barme G. The role of urinary potassium in the pathogenesis and diagnosis of interstitial cystitis. J Urol 1998; 159:1862-1867.
16. Parsons CL, Zupkas P, Parsons JK. Intravesical potassium sensitivity in patients with interstitial cystitis and urethral syndrome. Urology 2001; 57:428-433.
17. Parsons CL, Albo M. Intravesical potassium sensitivity in patients with prostatitis. J Urol 2002; 168:1054-1057.
18. Parsons CL. Prostatitis, interstitial cystitis, chronic pelvic pain, and urethral syndrome share a common pathophysiology: lower urinary dysfunctional epithelium and potassium recycling. Urology 2003; 62:976-982.
19. Rosenberg MT, Page SA, Roth L, Areaux D, Thallman C, Kval TE. Tolerability of the potassium sensitivity test for interstitial cystitis. Presented at: Research Insights Into Interstitial Cystitis: A Basic and Clinical Science Symposium; October 30-November 1, 2003; Alexandria, Va.
20. Pontari MA. Use of cystoscopy, bladder biopsy and hydrodistension in the diagnosis and treatment of interstitial cystitis. Presented at: Research Insights Into Interstitial Cystitis: A Basic and Clinical Science Symposium; October 30-November 1, 2003; Alexandria, Va.
21. Hanno PM, Buehler J, Wein AJ. Use of amitriptyline in the treatment of interstitial cystitis. J Urol 1989; 141:846-848.
22. Parsons CL. Epithelial coating techniques in the treatment of interstitial cystitis. Urology 1997; 49(suppl 5A):100-104.
23. Parsons CL, Mulholland SG. Successful therapy of interstitial cystitis with pentosanpolysulfate. J Urol 1987; 138:513-516.
24. Mulholland SG, Hanno P, Parsons CL, Sant GR, Staskin DR. Pentosan polysulfate sodium for therapy of interstitial cystitis: a double-blind placebo-controlled clinical study. Urology 1990; 35:552-558.
25. Parsons CL, Benson G, Childs SJ, Hanno P, Sant GR, Webster G. A quantitatively controlled method to study prospectively interstitial cystitis and demonstrate the efficacy of pentosanpolysulfate. J Urol 1993; 150:845-848.
26. Hanno PM. Analysis of long-term Elmiron therapy for interstitial cystitis. Urology 1997; 49(suppl 5A):93-99.
27. Parsons CL, Forrest J, Nickel JC, et al. Effect of pentosan polysulfate therapy on intravesical potassium sensitivity. Urology 2002; 59:329-333.
28. Elmiron (pentosan polysulfate sodium capsules) prescribing information. Mountain View, CA: Alza Pharmaceuticals; 2002.
29. Parsons CL. Current strategies for managing interstitial cystitis. Exp Opin Pharmacother 2004; 5:287-293.
30. Sant GR. Intravesical 50% dimethyl sulfoxide (Rimso-50) in treatment of interstitial cystitis. Urology 1987; 29(suppl):17-21.
31. Moldwin RM, Sant GR. Interstitial cystitis: a pathophysiology and treatment update. Clin Obstet Gynecol 2002; 45:259-272.